'False and misleading': Former Visalia doctor pleads guilty, DOJ says

1 month ago 25
PopAds.net - The Best Popunder Adnetwork

TULARE COUNTY, Calif. (KSEE/KGPE) - A erstwhile doc from Visalia pleaded blameworthy Monday to manufacturing, selling and selling products that helium claimed efficaciously treated a assortment of aesculapian conditions, the Department of Justice said.

Federal prosecutors accidental Stephen D. Meis, 73, pleaded blameworthy to 1 number of instauration of misbranded drugs into interstate commerce.

‘Long COVID’ is keeping kids retired of school, Merced doc warns

Meis, the DOJ said, was the aesculapian doc of Golden Sunrise Pharmaceutical Inc. and Golden Sunrise Nuraceutical Inc. that manufactured, marketed and sold products that claimed to dainty a assortment of conditions.

On March 30, 2020, Meis and Golden Sunrise's Chief Executive Officer Huu Tieu, 62 of Porterville, began selling a acceptable of herbal mixtures they called the "Emergency D-Virus Plan of Care" arsenic a COVID-19 treatment, the DOJ said.

The treatment, the DOJ said, consisted of a container containing assorted vials of the company's cause products, including 1 called “Imunstem,” unneurotic with an “Emergency D-Virus Plan of Care” accusation sheet.

Meis and Tieu, the DOJ said mailed the products to assorted practitioners, nationalist officials and different individuals some wrong and extracurricular of the state.

The DOJ said the "labeling for the drugs, including the accusation expanse that accompanied the drugs, was mendacious and misleading and stated that ImunStem and different Golden Sunrise products were uniquely qualified to dainty and modify the people of the microorganism epidemic successful China and different countries."

The institution falsely claimed the products had been the archetypal dietary supplement successful the United States to beryllium approved arsenic a medicine medicine by the U.S. Food and Drug Administration (FDA) to dainty the COVID-19 virus, prosecutors say. However, the drugs were not FDA approved, and nary of the company's products had ever been approved.

On June 12, 2024, Tieu was sentenced to 18 months successful situation for the instauration of misbranded drugs into interstate commerce. Meis is scheduled to beryllium sentenced by U.S. District Judge Jennifer L. Thurston connected July 14, 2025. Meis faces a maximum statutory punishment of 12 months successful situation and a $100,000 fine.

Read Entire Article